ARTG 475370saypha rich - Dermal tissue reconstructive material, microbe-derived
ARTG ID: 475370 · AA-Med Pty Ltd · Croma-Pharma GmbH · Class III · Started January 08, 2025
Good Name: AA-Med Pty Ltd - saypha rich - Dermal tissue reconstructive material, microbe-derived
- Risk Class
- Class III
- Product Type
- Procedure Pack
- ARTG Category
- General
- ARTG ID
- 475370
- Start Date
- January 08, 2025
- Effective Date
- January 08, 2025
- Name
- AA-Med Pty Ltd
- Country
- Austria
- Address
- Industriezeile 6, Leobendorf, 2100
The intended aesthetic purpose of saypha rich is to replenish the loss of hyaluronic acid. It is indicated to maintain hydration, to improve tone and elasticity of the skin and, thereby, correct fine lines on the face, including lateral canthal lines (also called “crow's feet”) and perioral rhytids (also called “smile lines” or “smoker's lines”). It is indicated to be injected into the superficial dermal tissue.
Access comprehensive regulatory information for saypha rich - Dermal tissue reconstructive material, microbe-derived in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 475370 and sponsored by AA-Med Pty Ltd, manufactured by Croma-Pharma GmbH in Austria. The device registration started on January 08, 2025.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.